Back to Journals » Biologics: Targets and Therapy » Volume 1 » Issue 2

Nilotinib: a novel encouraging therapeutic option for chronic myeloid leukemia patients with imatinib resistance or intolerance

       
Total article views   HTML views PDF downloads Totals
5,195 Dovepress* 5,195+ 1,676 6,871
Totals 5,195 1,676 6,871
*Since 15 November 2007
+Since July 2016

View citations on Google Scholar